News Sanofi invests in new Canadian vaccine manufacturing plant Sanofi is investing 350 million euros in a new vaccine manufacturing facility at its Canadian headquarters in Toronto.
News Call for new restrictions on UK vaccine prices Proposals also include fresh attack on drug prices
News Prokarium raises $10m for 'game changer' synthetic bio vacci... UK company Prokarium has raised $10 million to develop groundbreaking synthetic biology techniques to create a new generation of vaccines, which could be taken orally, and not have to be ke
News Ex-GSK chiefs Witty and Slaoui join biotech investors Former GSK CEO Sir Andrew Witty, and his former drug development chief, Moncef Slaoui have both lined up new jobs as life science investors.
News Tipped to hit $1bn, GSK’s Shingrix gains committee approval GlaxoSmithKline’s shingles vaccine Shingrix has gained the unanimous backing of an FDA advisory committee.
News NICE changes stance on Genmab's cervical cancer drug After saying it couldn't recommend Genmab's cervical cancer therapy Tivdak for use by the NHS, reimbursement authority NICE has had a change of heart.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
